{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T10:51:41Z","timestamp":1793875901267,"version":"4.7.0"},"reference-count":170,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T00:00:00Z","timestamp":1671667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>As a systemic autoimmune disease, rheumatoid arthritis (RA) usually causes damage not only to joints, but also to other tissues and organs including the heart, kidneys, lungs, digestive system, eyes, skin, and nervous system. Excessive complications are closely related to the prognosis of RA patients and even lead to increased mortality. This article summarizes the serious complications of RA, focusing on its incidence, pathogenesis, clinical features, and treatment methods, aiming to provide a reference for clinicians to better manage the complications of RA.<\/jats:p>","DOI":"10.3389\/fimmu.2022.1051082","type":"journal-article","created":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T13:04:50Z","timestamp":1671714290000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":265,"title":["Systemic complications of rheumatoid arthritis: Focus on pathogenesis and treatment"],"prefix":"10.3389","volume":"13","author":[{"given":"Di","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiqi","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhou","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/cells9040880","article-title":"Update on the pathomechanism, diagnosis, and treatment options for rheumatoid arthritis","volume":"9","author":"Lin","year":"2020","journal-title":"Cells"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216694","article-title":"Is the epidemiology of rheumatoid arthritis changing? results from a population-based incidence study, 1985-2014","volume":"79","author":"Myasoedova","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-0413-5","article-title":"Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes","volume":"16","author":"Nygaard","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.03.008","article-title":"T-Cells interact with b cells, dendritic cells, and fibroblast-like synoviocytes as hub-like key cells in rheumatoid arthritis","volume":"70","author":"Hu","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01395","article-title":"Regulation of immune responses and chronic inflammation by fibroblast-like synoviocytes","volume":"10","author":"Yoshitomi","year":"2019","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22041742","article-title":"Overview of MMP-13 as a promising target for the treatment of osteoarthritis","volume":"22","author":"Hu","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000010920","article-title":"Inhibition of NF-\u03baB signaling pathway induces apoptosis and suppresses proliferation and angiogenesis of human fibroblast-like synovial cells in rheumatoid arthritis","volume":"97","author":"Xia","year":"2018","journal-title":"Med (Baltimore)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"22168","DOI":"10.1038\/s41598-021-01692-7","article-title":"Phenotypic and functional characterization of synovial fluid-derived fibroblast-like synoviocytes in rheumatoid arthritis","volume":"11","author":"K\u00f8ster","year":"2021","journal-title":"Sci Rep"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102735","article-title":"Beyond the joints, the extra-articular manifestations in rheumatoid arthritis","volume":"20","author":"Conforti","year":"2021","journal-title":"Autoimmun Rev"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206785","article-title":"Identification of novel antiacetylated vimentin antibodies in patients with early inflammatory arthritis","volume":"75","author":"Juarez","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000452","article-title":"Rheumatoid arthritis and citrullination","volume":"30","author":"Darrah","year":"2018","journal-title":"Curr Opin Rheumatol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60826-4","article-title":"Rheumatoid arthritis","volume":"376","author":"Scott","year":"2010","journal-title":"Lancet"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-017-0627-z","article-title":"The role of autoantibodies in the pathophysiology of rheumatoid arthritis","volume":"39","author":"Derksen","year":"2017","journal-title":"Semin Immunopathol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2019.04.018","article-title":"Extra-articular manifestations and comorbidity in rheumatoid arthritis: Potential impact of pre-rheumatoid arthritis prevention","volume":"41","author":"Giles","year":"2019","journal-title":"Clin Ther"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10030509","article-title":"The key comorbidities in patients with rheumatoid arthritis: A narrative review","volume":"10","author":"Taylor","year":"2021","journal-title":"J Clin Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2019.08.010","article-title":"Comorbidities as risk factors for rheumatoid arthritis and their accrual after diagnosis","volume":"94","author":"Kronzer","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"B17","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1136\/annrheumdis-2021-220973","article-title":"EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis","volume":"81","author":"Nagy","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2019.05.005","article-title":"Rheumatoid arthritis (RA) and cardiovascular disease","volume":"18","author":"Blum","year":"2019","journal-title":"Autoimmun Rev"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/life11101042","article-title":"Ischemic heart disease and rheumatoid arthritis-two conditions, the same background","volume":"11","author":"Rezu\u015f","year":"2021","journal-title":"Life (Basel)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/cells10040881","article-title":"Cardiac dysfunction in rheumatoid arthritis: The role of inflammation","volume":"10","author":"Chen","year":"2021","journal-title":"Cells"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2019-001032","article-title":"Pathogenesis of ischaemic and non-ischaemic heart diseases in rheumatoid arthritis","volume":"6","author":"B\u0142yszczuk","year":"2020","journal-title":"RMD Open"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.588776","article-title":"T Cells in autoimmunity-associated cardiovascular diseases","volume":"11","author":"Schwartz","year":"2020","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00648","article-title":"Roles of exosomes derived from immune cells in cardiovascular diseases","volume":"10","author":"Wu","year":"2019","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/367359","article-title":"Cardiovascular involvement in autoimmune diseases","volume":"2014","author":"Amaya-Amaya","year":"2014","journal-title":"BioMed Res Int"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11102704","article-title":"Cardiovascular disease risk in rheumatoid arthritis anno 2022","volume":"11","author":"Dijkshoorn","year":"2022","journal-title":"J Clin Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2017.04.046","article-title":"Long-term mortality in patients with ST-segment elevation myocardial infarction is associated with anti-citrullinated protein antibodies","volume":"240","author":"Hermans","year":"2017","journal-title":"Int J Cardiol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-020-04691-5","article-title":"Cardiovascular risk assessment in patients with rheumatoid arthritis using carotid ultrasound b-mode imaging","volume":"40","author":"Jamthikar","year":"2020","journal-title":"Rheumatol Int"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-017-8635-2","article-title":"Sex and cardiovascular involvement in inflammatory joint diseases","volume":"56","author":"Casta\u00f1eda","year":"2019","journal-title":"Clin Rev Allergy Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/biom11010081","article-title":"Endothelial dysfunction and extra-articular neurological manifestations in rheumatoid arthritis","volume":"11","author":"Maiuolo","year":"2021","journal-title":"Biomolecules"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/medicina56090445","article-title":"Echocardiography in autoimmune rheumatic diseases for diagnosis and prognosis of cardiovascular complications","volume":"56","author":"Makavos","year":"2020","journal-title":"Medicina (Kaunas)"},{"key":"B31","doi-asserted-by":"publisher","first-page":"5867","DOI":"10.1038\/s41598-018-24323-0","article-title":"Cardiac eccentric remodeling in patients with rheumatoid arthritis","volume":"8","author":"Pascale","year":"2018","journal-title":"Sci Rep"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00401.2020","article-title":"Proarrhythmic electrophysiological and structural remodeling in rheumatoid arthritis","volume":"319","author":"Patel","year":"2020","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"17","DOI":"10.15420\/aer.2020.43","article-title":"Arrhythmias and conduction disturbances in autoimmune rheumatic disorders","volume":"10","author":"Plastiras","year":"2021","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"B34","doi-asserted-by":"publisher","first-page":"S82","DOI":"10.21037\/atm.2018.10.72","article-title":"Cardiovascular disease in patients with rheumatoid arthritis: impact of classic and disease-specific risk factors","volume":"6","author":"Cavalli","year":"2018","journal-title":"Ann Transl Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa789","article-title":"Arterial wall inflammation is increased in rheumatoid arthritis compared with osteoarthritis, as a marker of early atherosclerosis","volume":"60","author":"Agca","year":"2021","journal-title":"Rheumatol (Oxford)"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.15537\/smj.2021.42.6.20200753","article-title":"Vascular cell adhesion molecule-1 in rheumatoid arthritis patients: Relation to disease activity, oxidative stress, and systemic inflammation","volume":"42","author":"Salem","year":"2021","journal-title":"Saudi Med J"},{"key":"B37","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1155\/2019\/7536805.7536805","article-title":"Oxidative stress in rheumatoid arthritis: what the future might hold regarding novel biomarkers and add-on therapies","volume":"2019","author":"da Fonseca","year":"2019","journal-title":"Oxid Med Cell Longevity"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11061153","article-title":"The role of reactive oxygen species in the rheumatoid arthritis-associated synovial microenvironment","volume":"11","author":"Wang","year":"2022","journal-title":"Antioxid (Basel)"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa725","article-title":"The role of interleukin-6 trans-signalling on cardiovascular dysfunction in inflammatory arthritis","volume":"60","author":"Davies","year":"2021","journal-title":"Rheumatology"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy128","article-title":"Interleukin-1 blockade in cardiovascular diseases: a clinical update","volume":"39","author":"Buckley","year":"2018","journal-title":"Eur Heart J"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2020.11.002","article-title":"Prevalence, risk factors and proteomic bioprofiles associated with heart failure in rheumatoid arthritis: The RA-HF study","volume":"85","author":"Ferreira","year":"2021","journal-title":"Eur J Intern Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1146\/annurev-pharmtox-010818-021136","article-title":"Drug targets for heart failure with preserved ejection fraction: A mechanistic approach and review of contemporary clinical trials","volume":"59","author":"Patel","year":"2019","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s40744-019-00189-0","article-title":"Autoimmunity and inflammation link to cardiovascular disease risk in rheumatoid arthritis","volume":"7","author":"DeMizio","year":"2020","journal-title":"Rheumatol Ther"},{"key":"B44","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/1074248419871902","article-title":"Risks of cardiovascular disease and beyond in prescription of nonsteroidal anti-inflammatory drugs","volume":"25","author":"Rane","year":"2020","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20174262","article-title":"Cyclo-oxygenase (COX) inhibitors and cardiovascular risk: Are non-steroidal anti-inflammatory drugs really anti-inflammatory","volume":"20","author":"Khan","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.13.jrv60011","article-title":"Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2","volume":"296","author":"McGettigan","year":"2006","journal-title":"JAMA"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.15420\/ecr.2020.44","article-title":"Atherosclerotic cardiovascular disease in rheumatoid arthritis: Impact of inflammation and antirheumatic treatment","volume":"16","author":"Kerola","year":"2021","journal-title":"Eur Cardiol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"296","DOI":"10.18553\/jmcp.2021.27.3.296","article-title":"Statin use and mortality in rheumatoid arthritis: an incident user cohort study","volume":"27","author":"Chhibber","year":"2021","journal-title":"J Manag Care Spec Pharm"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0193297","article-title":"Pattern of risks of rheumatoid arthritis among patients using statins: A cohort study with the clinical practice research datalink","volume":"13","author":"de Jong","year":"2018","journal-title":"PloS One"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2020.03.008","article-title":"Effect of statin use on the risk of rheumatoid arthritis: A systematic review and meta-analysis","volume":"50","author":"Myasoedova","year":"2020","journal-title":"Semin Arthritis Rheumatol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2018.07.004","article-title":"Methotrexate mechanism in treatment of rheumatoid arthritis","volume":"86","author":"Friedman","year":"2019","journal-title":"Joint Bone Spine"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-220125","article-title":"Investigating changes in disease activity as a mediator of cardiovascular risk reduction with methotrexate use in rheumatoid arthritis","volume":"80","author":"Johnson","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k1036","article-title":"Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications","volume":"361","author":"England","year":"2018","journal-title":"BMJ"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202012476","article-title":"Hydroxychloroquine in rheumatic autoimmune disorders and beyond","volume":"12","author":"Nirk","year":"2020","journal-title":"EMBO Mol Med"},{"key":"B55","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s42358-020-00134-8","article-title":"Revisiting hydroxychloroquine and chloroquine for patients with chronic immunity-mediated inflammatory rheumatic diseases","volume":"60","author":"Dos Reis Neto","year":"2020","journal-title":"Adv Rheumatol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.631869","article-title":"Hydroxychloroquine does not increase the risk of cardiac arrhythmia in common rheumatic diseases: A nationwide population-based cohort study","volume":"12","author":"Lo","year":"2021","journal-title":"Front Immunol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1136\/annrheumdis-2017-211836","article-title":"Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysis","volume":"77","author":"Rempenault","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.5830\/CVJA-2018-018","article-title":"Rheumatoid arthritis and risk of cardiovascular disease","volume":"29","author":"Meyer","year":"2018","journal-title":"Cardiovasc J Afr"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2018.06.099","article-title":"Anti-TNF modulation reduces myocardial inflammation and improves cardiovascular function in systemic rheumatic diseases","volume":"270","author":"Ntusi","year":"2018","journal-title":"Int J Cardiol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1002\/biof.1599","article-title":"Resveratrol ameliorates rheumatoid arthritis via activation of SIRT1-Nrf2 signaling pathway","volume":"46","author":"Wang","year":"2020","journal-title":"Biofactors"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24071297","article-title":"Resveratrol and quercetin administration improves antioxidant DEFENSES and reduces fatty liver in metabolic syndrome rats","volume":"24","author":"Rubio-Ruiz","year":"2019","journal-title":"Molecules"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2019.10273","article-title":"Resveratrol alleviates inflammatory injury and enhances the apoptosis of fibroblast\u2212like synoviocytes via mitochondrial dysfunction and ER stress in rats with adjuvant arthritis","volume":"20","author":"Lu","year":"2019","journal-title":"Mol Med Rep"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26010229","article-title":"Anti-inflammatory action and mechanisms of resveratrol","volume":"26","author":"Meng","year":"2021","journal-title":"Molecules"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20181995","article-title":"AMPK is associated with the beneficial effects of antidiabetic agents on cardiovascular diseases","volume":"39","author":"Lu","year":"2019","journal-title":"Biosci Rep"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2020.05.008","article-title":"Metformin, an AMPK activator, inhibits activation of FLSs but promotes HAPLN1 secretion","volume":"17","author":"Chen","year":"2020","journal-title":"Mol Ther Methods Clin Dev"},{"key":"B66","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1177\/1759720X17752036","article-title":"Investigational therapies targeting the granulocyte macrophage colony-stimulating factor receptor-\u03b1 in rheumatoid arthritis: focus on mavrilimumab","volume":"10","author":"Cook","year":"2018","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.920137","article-title":"The association between MUC5B mutations and clinical outcome in patients with rheumatoid arthritis-associated interstitial lung disease: A retrospective exploratory study in China","volume":"26","author":"Wang","year":"2020","journal-title":"Med Sci Monit"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1007\/s40674-020-00160-z","article-title":"Rheumatoid arthritis-associated interstitial lung disease: Current update on prevalence, risk factors, and pharmacologic treatment","volume":"6","author":"Huang","year":"2020","journal-title":"Curr Treatm Opt Rheumatol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000028501","article-title":"Consensus recommendations on managing the selected comorbidities including cardiovascular disease, osteoporosis, and interstitial lung disease in rheumatoid arthritis","volume":"101","author":"Yu","year":"2022","journal-title":"Med (Baltimore)"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10061367","article-title":"Novel biomarkers, diagnostic and therapeutic approach in rheumatoid arthritis interstitial lung disease-a narrative review","volume":"10","author":"Florescu","year":"2022","journal-title":"Biomedicines"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.200863","article-title":"Lifestyle and clinical risk factors for incident rheumatoid arthritis-associated interstitial lung disease","volume":"48","author":"Kronzer","year":"2021","journal-title":"J Rheumatol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab441","article-title":"Pulmonary fibrosis in relation to genetic loci in an inception cohort of patients with early rheumatoid arthritis from northern Sweden","volume":"61","author":"J\u00f6nsson","year":"2022","journal-title":"Rheumatol (Oxford)"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7262065","article-title":"Risk factors and changes of peripheral NK and T cells in pulmonary interstitial fibrosis of patients with rheumatoid arthritis","volume":"2019","author":"Lai","year":"2019","journal-title":"Can Respir J"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000787","article-title":"Interstitial lung disease throughout the rheumatoid arthritis disease course","volume":"33","author":"McDermott","year":"2021","journal-title":"Curr Opin Rheumatol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000703","article-title":"Management issues in rheumatoid arthritis-associated interstitial lung disease","volume":"32","author":"England","year":"2020","journal-title":"Curr Opin Rheumatol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2021.105133","article-title":"Predictors of mortality in rheumatoid arthritis-associated lung disease: A retrospective study on ten years","volume":"88","author":"Ekici","year":"2021","journal-title":"Joint Bone Spine"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0226084","article-title":"Meta-analysis of the radiological and clinical features of usual interstitial pneumonia (UIP) and nonspecific interstitial pneumonia (NSIP)","volume":"15","author":"Ebner","year":"2020","journal-title":"PloS One"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.837133","article-title":"Interstitial lung disease in rheumatoid arthritis: A practical review","volume":"9","author":"Laria","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1515\/med-2020-0225","article-title":"Rheumatoid arthritis increases the risk of pleural empyema","volume":"15","author":"Liao","year":"2020","journal-title":"Open Med (Wars)"},{"key":"B80","doi-asserted-by":"publisher","first-page":"210011","DOI":"10.1183\/16000617.0011-2021","article-title":"Rheumatoid arthritis-interstitial lung disease: manifestations and current concepts in pathogenesis and management","volume":"30","author":"Kadura","year":"2021","journal-title":"Eur Respir Rev"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2016.349","article-title":"Clinical characteristics associated with occurrence and poor prognosis of interstitial lung disease in rheumatoid arthritis","volume":"34","author":"Yang","year":"2019","journal-title":"Korean J Intern Med"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.22367","article-title":"Rheumatoid arthritis and associated lung diseases: A comprehensive review","volume":"14","author":"Azam","year":"2022","journal-title":"Cureus"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-028466","article-title":"Is incident rheumatoid arthritis interstitial lung disease associated with methotrexate treatment? results from a multivariate analysis in the ERAS and ERAN inception cohorts","volume":"9","author":"Kiely","year":"2019","journal-title":"BMJ Open"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.5152\/eurjrheum.2019.19036","article-title":"Comprehensive review of current diagnostic and treatment approaches to interstitial lung disease associated with rheumatoid arthritis","volume":"6","author":"Bes","year":"2018","journal-title":"Eur J Rheumatol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1002\/art.41451","article-title":"Methotrexate pulmonary toxicity: Deep inspiration","volume":"72","author":"Kremer","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1093\/rheumatology\/key208","article-title":"The British society for rheumatology biologic DMARD safety guidelines in inflammatory arthritis","volume":"58","author":"Holroyd","year":"2019","journal-title":"Rheumatol (Oxford)"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-021-05854-w","article-title":"Abatacept in rheumatoid arthritis-associated interstitial lung disease: short-term outcomes and predictors of progression","volume":"40","author":"Tardella","year":"2021","journal-title":"Clin Rheumatol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.2226-18","article-title":"Effect of biological disease-modifying anti-rheumatic drugs on airway and interstitial lung disease in patients with rheumatoid arthritis","volume":"58","author":"Kurata","year":"2019","journal-title":"Intern Med"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9010277","article-title":"Safety of abatacept in Italian patients with rheumatoid arthritis and interstitial lung disease: A multicenter retrospective study","volume":"9","author":"Cassone","year":"2020","journal-title":"J Clin Med"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.7573\/dic.2020-8-7","article-title":"Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease","volume":"10","author":"Vacchi","year":"2021","journal-title":"Drugs Context"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9103070","article-title":"Rituximab in the treatment of interstitial lung disease associated with autoimmune diseases: Experience from a single referral center and literature review","volume":"9","author":"Atienza-Mateo","year":"2020","journal-title":"J Clin Med"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kex072","article-title":"Effect of rituximab on the progression of rheumatoid arthritis-related interstitial lung disease: 10 years' experience at a single centre","volume":"56","author":"Md Yusof","year":"2017","journal-title":"Rheumatol (Oxford)"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker106a","article-title":"BSR and BHPR standards, guidelines and audit working group. BSR and BHPR guidelines on the use of rituximab in rheumatoid arthritis","volume":"50","author":"Bukhari","year":"2011","journal-title":"Rheumatol (Oxford)"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908681","article-title":"Nintedanib in progressive fibrosing interstitial lung diseases","volume":"381","author":"Flaherty","year":"2019","journal-title":"N Engl J Med"},{"key":"B95","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1097\/CM9.0000000000001235","article-title":"Successful treatment with tocilizumab in a patient with rapidly progressive interstitial lung disease with positive anti-melanoma differentiation-associated gene-5 antibody","volume":"134","author":"Teng","year":"2020","journal-title":"Chin Med J"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1111\/imj.14670","article-title":"Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicentre retrospective study","volume":"50","author":"Manfredi","year":"2020","journal-title":"Intern Med J"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.684699","article-title":"Interstitial lung disease in connective tissue disease: A common lesion with heterogeneous mechanisms and treatment considerations","volume":"12","author":"Shao","year":"2021","journal-title":"Front Immunol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X221074457","article-title":"The role of antifibrotics in the treatment of rheumatoid arthritis-associated interstitial lung disease","volume":"14","author":"Liang","year":"2022","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006322.pub4","article-title":"Pulmonary rehabilitation for interstitial lung disease","volume":"2","author":"Dowman","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2019.12.27","article-title":"Aerobic and breathing exercises improve dyspnea, exercise capacity and quality of life in idiopathic pulmonary fibrosis patients: systematic review and meta-analysis","volume":"12","author":"Hanada","year":"2020","journal-title":"J Thorac Dis"},{"key":"B101","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1298\/ptr.R0012","article-title":"Respiratory impairment, limited activity, and pulmonary rehabilitation in patients with interstitial lung disease","volume":"24","author":"Kozu","year":"2021","journal-title":"Phys Ther Res"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.4081\/monaldi.2021.1925","article-title":"Acute effect of oxygen therapy on exercise tolerance and dyspnea perception in ILD patients","volume":"92","author":"Ora","year":"2021","journal-title":"Monaldi Arch Chest Dis"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.171315","article-title":"Rheumatoid arthritis-interstitial lung disease in the united states: Prevalence, incidence, and healthcare costs and mortality","volume":"46","author":"Raimundo","year":"2019","journal-title":"J Rheumatol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-021-05704-9","article-title":"Survival and outcomes after lung transplantation for connective tissue disease-associated interstitial lung diseases","volume":"40","author":"Yang","year":"2021","journal-title":"Clin Rheumatol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2019.04.62","article-title":"Pharmacotherapy and adjunctive treatment for idiopathic pulmonary fibrosis (IPF)","volume":"11","author":"Saito","year":"2019","journal-title":"J Thorac Dis"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-020-02520-y","article-title":"Clinical profile and outcome of patients with chronic inflammatory arthritis and metabolic syndrome","volume":"16","author":"Cioffi","year":"2021","journal-title":"Intern Emerg Med"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.855141","article-title":"Prevalence of metabolic syndrome in patients with rheumatoid arthritis: An updated systematic review and meta-analysis","volume":"9","author":"Cai","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"B108","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2478\/jtim-2020-0015","article-title":"Metabolic syndrome and atherogenic indices in rheumatoid arthritis and their relationship with disease activity: A hospital-based study from northeast India","volume":"8","author":"Bhattacharya","year":"2020","journal-title":"J Transl Int Med"},{"key":"B109","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.bj.2019.01.007","article-title":"Incidence and effect of insulin resistance on progression of atherosclerosis in rheumatoid arthritis patients of long disease duration","volume":"42","author":"Guin","year":"2019","journal-title":"BioMed J"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.2147\/JMDH.S285469","article-title":"Association of rheumatoid arthritis with diabetic comorbidity: Correlating accelerated insulin resistance to inflammatory responses in patients","volume":"14","author":"Verma","year":"2021","journal-title":"J Multidiscip Healthc"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-044749","article-title":"Cumulative inflammatory burden and obesity as determinants of insulin resistance in patients with established rheumatoid arthritis: cross-sectional study","volume":"11","author":"Manrique-Arija","year":"2021","journal-title":"BMJ Open"},{"key":"B112","doi-asserted-by":"publisher","first-page":"16364","DOI":"10.1038\/s41598-020-73347-y","article-title":"Elevated adipose tissue associated IL-2 expression in obesity correlates with metabolic inflammation and insulin resistance","volume":"10","author":"Kochumon","year":"2020","journal-title":"Sci Rep"},{"key":"B113","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.bcp.2019.03.030","article-title":"Adipokines: Linking metabolic syndrome, the immune system, and arthritic diseases","volume":"165","author":"Francisco","year":"2019","journal-title":"Biochem Pharmacol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3390\/cells10020216","article-title":"Adipokines and autoimmunity in inflammatory arthritis","volume":"10","author":"Neumann","year":"2021","journal-title":"Cells"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1177\/1179544120985860","article-title":"Assessment of adipokines, CXCL16 chemokine levels in patients with rheumatoid arthritis combined with metabolic syndrome","volume":"14","author":"Turgunova","year":"2021","journal-title":"Clin Med Insights Arthritis Musculoskelet Disord"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0210459","article-title":"Immunosuppressive treatment and the risk of diabetes in rheumatoid arthritis","volume":"14","author":"Lillegraven","year":"2019","journal-title":"PloS One"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v12.i3.238","article-title":"Anti- and non-tumor necrosis factor-\u03b1-targeted therapies effects on insulin resistance in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis","volume":"12","author":"Wang","year":"2021","journal-title":"World J Diabetes"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2019-000897","article-title":"Comparative effect of tumour necrosis factor inhibitors versus other biological agents on cardiovascular risk-associated biomarkers in patients with rheumatoid arthritis","volume":"5","author":"Virone","year":"2019","journal-title":"RMD Open"},{"key":"B119","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s40744-020-00219-2","article-title":"Understanding the role of interleukin-6 (IL-6) in the joint and beyond: A comprehensive review of IL-6 inhibition for the management of rheumatoid arthritis","volume":"7","author":"Favalli","year":"2020","journal-title":"Rheumatol Ther"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.117045","article-title":"Inhibition of JAK-STAT and NF-\u03baB signalling systems could be a novel therapeutic target against insulin resistance and type 2 diabetes","volume":"239","author":"Bako","year":"2019","journal-title":"Life Sci"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.29593","article-title":"Janus kinase inhibitors: A therapeutic strategy for cancer and autoimmune diseases","volume":"235","author":"Hosseini","year":"2020","journal-title":"J Cell Physiol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-020-01501-z","article-title":"Real-world evidence to contextualize clinical trial results and inform regulatory decisions: Tofacitinib modified-release once-daily vs immediate-release twice-daily for rheumatoid arthritis","volume":"38","author":"Cohen","year":"2021","journal-title":"Adv Ther"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.554961","article-title":"Multi-target approaches in metabolic syndrome","volume":"11","author":"Lillich","year":"2021","journal-title":"Front Pharmacol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11092382","article-title":"Secondary osteoporosis and metabolic bone diseases","volume":"11","author":"Sobh","year":"2022","journal-title":"J Clin Med"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.601618","article-title":"Osteoporosis in rheumatoid arthritis: Dangerous liaisons","volume":"7","author":"Llorente","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"B126","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11657-020-00867-5","article-title":"Establishment and verification of an osteoporosis risk model in patients with rheumatoid arthritis: a valuable new model","volume":"16","author":"Yan","year":"2021","journal-title":"Arch Osteoporos"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-020-04593-6","article-title":"Osteoporosis in patients with rheumatoid arthritis: trends in the German national database 2007-2017","volume":"40","author":"Lindner","year":"2020","journal-title":"Rheumatol Int"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/3830212","article-title":"Molecular and cellular pathways contributing to joint damage in rheumatoid arthritis","volume":"2020","author":"Fang","year":"2020","journal-title":"Mediators Inflamm"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01483","article-title":"How autoantibodies regulate osteoclast induced bone loss in rheumatoid arthritis","volume":"10","author":"Steffen","year":"2019","journal-title":"Front Immunol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2019.05.012","article-title":"Complement and its environmental determinants in the progression of human rheumatoid arthritis","volume":"112","author":"Bemis","year":"2019","journal-title":"Mol Immunol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214967","article-title":"Anticitrullinated protein antibodies facilitate migration of synovial tissue-derived fibroblasts","volume":"78","author":"Sun","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N Engl J Med"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcli.2019.12.005","article-title":"Effect of antiresorptive and bone forming treatments in bone erosions in rheumatoid arthritis","volume":"154","author":"Azuaga-Pi\u00f1ango","year":"2020","journal-title":"Med Clin (Barc)"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-017-0861-4","article-title":"Assessment of the effects of switching oral bisphosphonates to denosumab or daily teriparatide in patients with rheumatoid arthritis","volume":"36","author":"Ebina","year":"2018","journal-title":"J Bone Miner Metab"},{"key":"B135","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.bone.2018.07.013","article-title":"Real-world effectiveness of teriparatide on fracture reduction in patients with osteoporosis and comorbidities or risk factors for fractures: Integrated analysis of 4 prospective observational studies","volume":"116","author":"Langdahl","year":"2018","journal-title":"Bone"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22168855","article-title":"Vitamin d deficiency, osteoporosis and effect on autoimmune diseases and hematopoiesis: A review","volume":"22","author":"De Martinis","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00095","article-title":"Senescent T-cells promote bone loss in rheumatoid arthritis","volume":"9","author":"Fessler","year":"2018","journal-title":"Front Immunol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-020-01395-x","article-title":"Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: An international, double-blind, randomized controlled phase 3 study-Asian subgroup analysis","volume":"37","author":"Huang","year":"2020","journal-title":"Adv Ther"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X18805759","article-title":"New and emerging concepts in the use of denosumab for the treatment of osteoporosis","volume":"10","author":"Lewiecki","year":"2018","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"B140","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1136\/annrheumdis-2018-214827","article-title":"Effects of the anti-RANKL antibody denosumab on joint structural damage in patients with rheumatoid arthritis treated with conventional synthetic disease-modifying antirheumatic drugs (DESIRABLE study): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"78","author":"Takeuchi","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-019-00714-4","article-title":"Pharmacological management of osteoporosis in rheumatoid arthritis patients: A review of the literature and practical guide","volume":"36","author":"Raterman","year":"2019","journal-title":"Drugs Aging"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.190299","article-title":"Comparative persistence of methotrexate and tumor necrosis factor inhibitors in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis","volume":"47","author":"George","year":"2020","journal-title":"J Rheumatol"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.3390\/cells11010132","article-title":"Regulation of TNF-induced osteoclast differentiation","volume":"11","author":"Yao","year":"2021","journal-title":"Cells"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10132905","article-title":"Bone metabolism and RANKL\/OPG ratio in rheumatoid arthritis women treated with TNF-\u03b1 inhibitors","volume":"10","author":"Jura-P\u00f3\u0142torak","year":"2021","journal-title":"J Clin Med"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23052871","article-title":"Inflammation and bone metabolism in rheumatoid arthritis: Molecular mechanisms of joint destruction and pharmacological treatments","volume":"23","author":"Maeda","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.783030","article-title":"Different effects of biologics on systemic bone loss protection in rheumatoid arthritis: An interim analysis of a three-year longitudinal cohort study","volume":"12","author":"Chen","year":"2021","journal-title":"Front Immunol"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-020-05910-9","article-title":"JAK\/STAT pathway and molecular mechanism in bone remodeling","volume":"47","author":"Sanpaolo","year":"2020","journal-title":"Mol Biol Rep"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1002\/art.41666","article-title":"Characterization and function of tumor necrosis factor and interleukin-6-Induced osteoclasts in rheumatoid arthritis","volume":"73","author":"Yokota","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aay4447","article-title":"JAK inhibition increases bone mass in steady-state conditions and ameliorates pathological bone loss by stimulating osteoblast function","volume":"12","author":"Adam","year":"2020","journal-title":"Sci Transl Med"},{"key":"B150","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s13256-021-02802-9","article-title":"Felty syndrome: a case report","volume":"15","author":"Gupta","year":"2021","journal-title":"J Med Case Rep"},{"key":"B151","doi-asserted-by":"publisher","first-page":"e20713","DOI":"10.7759\/cureus.20713","article-title":"Infective endocarditis-like presentation of felty syndrome: A case report","volume":"13","author":"Hoshina","year":"2021","journal-title":"Cureus"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1007\/s00393-021-01105-0","article-title":"Imitation eines felty-syndroms durch eine viszerale leishmaniasis bei rheumatoider arthritis unter therapie mit methotrexat und etanercept [Visceral leishmaniasis mimicking felty's syndrome in rheumatoid arthritis treated with methotrexate and etanercept]","volume":"81","author":"Ruffer","year":"2022","journal-title":"Z Rheumatol"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000023608","article-title":"Rheumatoid arthritis patients with peripheral blood cell reduction should be evaluated for latent felty syndrome: A case report","volume":"99","author":"Wu","year":"2020","journal-title":"Med (Baltimore)"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.24593","article-title":"The diagnosis felt(y) right: A case report of felty syndrome with limited articular involvement","volume":"14","author":"Serrano Santiago","year":"2022","journal-title":"Cureus"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.175729","article-title":"Somatic STAT3 mutations in felty syndrome: an implication for a common pathogenesis with large granular lymphocyte leukemia","volume":"103","author":"Savola","year":"2018","journal-title":"Haematologica"},{"key":"B156","doi-asserted-by":"publisher","first-page":"48","DOI":"10.22551\/2019.23.0602.10153","article-title":"Felty's syndrome - a rare case of febrile neutropenia","volume":"6","author":"Rodrigues","year":"2021","journal-title":"Arch Clin Cases"},{"key":"B157","article-title":"Felty syndrome. 2022 jul 4","volume-title":"StatPearls","author":"Patel","year":"2022"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.5152\/eurjrheumatol.2014.026","article-title":"Presentation of three cases followed up with a diagnosis of felty syndrome","volume":"1","author":"Yaz\u0131c\u0131","year":"2014","journal-title":"Eur J Rheumatol"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1080\/24725625.2020.1717740","article-title":"Successful abatacept treatment for felty's syndrome in a patient with rheumatoid arthritis","volume":"4","author":"Kimura","year":"2020","journal-title":"Mod Rheumatol Case Rep"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-020-04757-4","article-title":"Analysis of a single-institution cohort of patients with felty's syndrome and T-cell large granular lymphocytic leukemia in the setting of rheumatoid arthritis","volume":"41","author":"Gorodetskiy","year":"2021","journal-title":"Rheumatol Int"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1080\/03009742.2017.1334816","article-title":"Successful treatment of refractory neutropenia in felty's syndrome with rituximab","volume":"47","author":"Wang","year":"2018","journal-title":"Scand J Rheumatol"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-020-04588-3","article-title":"Tocilizumab treatment in felty's syndrome","volume":"40","author":"Li","year":"2020","journal-title":"Rheumatol Int"},{"key":"B163","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3109\/03009742.2016.1168482","article-title":"Sleep disturbance in patients with rheumatoid arthritis is related to fatigue, disease activity, and other patient-reported outcomes","volume":"46","author":"Austad","year":"2017","journal-title":"Scand J Rheumatol"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2007.09.001","article-title":"Sleep and rheumatologic disorders","volume":"12","author":"Abad","year":"2008","journal-title":"Sleep Med Rev"},{"key":"B165","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12955-016-0550-3","article-title":"Sleep quality in Chinese patients with rheumatoid arthritis: contributing factors and effects on health-related quality of life","volume":"14","author":"Guo","year":"2016","journal-title":"Health Qual Life Outcomes"},{"key":"B166","doi-asserted-by":"publisher","first-page":"44","DOI":"10.4021\/jocmr1648w","article-title":"Sleep quality in rheumatoid arthritis: relationship between the disease severity, depression, functional status and the quality of life","volume":"6","author":"Sariyildiz","year":"2014","journal-title":"J Clin Med Res"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.119727","article-title":"Investigation into the impact of abatacept on sleep quality in patients with rheumatoid arthritis, and the validity of the MOS-sleep questionnaire sleep disturbance scale","volume":"69","author":"Wells","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"B168","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1136\/ard.2003.007831","article-title":"Effect of the first infliximab infusion on sleep and alertness in patients with active rheumatoid arthritis","volume":"63","author":"Zamarr\u00f3n","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X20949088","article-title":"Real-world evidence of the impact of adalimumab on work productivity and sleep measures in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis","volume":"12","author":"Tektonidou","year":"2020","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110617","article-title":"Sleep disturbances and interleukin 6 receptor inhibition in rheumatoid arthritis","volume":"39","author":"Fragiadaki","year":"2012","journal-title":"J Rheumatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1051082\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T13:04:56Z","timestamp":1671714296000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1051082\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,22]]},"references-count":170,"alternative-id":["10.3389\/fimmu.2022.1051082"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.1051082","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,22]]},"article-number":"1051082"}}